Talphera (TLPH) Assets (2010 - 2026)
Talphera (TLPH) posted Assets of $26.8 million for Q2 2026, down 11.11% on a QoQ basis from $30.2 million in Q1 2026, and up 62.31% year-over-year from $16.5 million in Q2 2025.
Analysis
Talphera (TLPH) Assets (2010 - 2026) Analysis & Trends
Talphera has reported Assets for 17 years, with the latest figure at $26.8 million in Q2 2026.
- On a quarterly basis, Assets rose 62.31% year-over-year to $26.8 million in Q2 2026; TTM through Jun 2026 was $26.8 million, a 62.31% increase from a year earlier, with the FY2025 full-year figure at $29.7 million, up 62.97% from the prior year.
- Assets was $26.8 million for Q2 2026 at Talphera, down from $30.2 million in the prior quarter.
- The five-year high for Assets was $72.0 million in Q1 2022, with the low at $15.0 million in Q1 2025.
- Average Assets over 5 years is $30.7 million, with a median of $26.5 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2026: Assets slumped 68.42% in 2023, then surged 101.1% in 2026.
- Over 5 years, Assets stood at $47.5 million in 2022, then plunged by 57.05% to $20.4 million in 2023, then declined by 10.59% to $18.2 million in 2024, then surged by 62.97% to $29.7 million in 2025, then decreased by 9.8% to $26.8 million in 2026.
- The last three Assets figures came in at $26.8 million (Q2 2026), $30.2 million (Q1 2026), and $29.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 95.64 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 49.36 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 27.42 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 41.73 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 10.03 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 10.96 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 5.56 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 32.09 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 5.31 Bn |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - | 26.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.81 Mn |
| Mar 31, 2026 | 30.16 Mn |
| Dec 31, 2025 | 29.72 Mn |
| Sep 30, 2025 | 30.74 Mn |
| Jun 30, 2025 | 16.52 Mn |
| Mar 31, 2025 | 15.00 Mn |
| Dec 31, 2024 | 18.24 Mn |
| Sep 30, 2024 | 21.01 Mn |
| Jun 30, 2024 | 24.86 Mn |
| Mar 31, 2024 | 28.77 Mn |
| Dec 31, 2023 | 20.40 Mn |
| Sep 30, 2023 | 23.26 Mn |
| Jun 30, 2023 | 17.73 Mn |
| Mar 31, 2023 | 26.29 Mn |
| Dec 31, 2022 | 47.49 Mn |
| Sep 30, 2022 | 48.31 Mn |
| Jun 30, 2022 | 56.13 Mn |
| Mar 31, 2022 | 71.97 Mn |
| Dec 31, 2021 | 77.89 Mn |
| Sep 30, 2021 | 72.26 Mn |